Acceptability of willingness to pay techniques to consumers

Health Expectations

Volumn 5, Issue 4, 2002, Pages 341-356

  Taylor, Susan J ^a   Armour, Carol L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acceptability to consumers; Consumer preference; Contingent valuation; Discrete choice experiment; Willingness to pay

Indexed keywords

OXYTOCIN; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; AMNIOTOMY; ARTICLE; AUSTRALIA; CHILDBIRTH; CONSUMER; FEMALE; HEALTH SURVEY; HUMAN; INCOME; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PROSPECTIVE PAYMENT; TEACHING HOSPITAL; TECHNIQUE;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; DECISION MAKING; FEMALE; FINANCING, PERSONAL; HEALTH SERVICES RESEARCH; HOSPITAL CHARGES; HOSPITALS, TEACHING; HUMANS; NEW SOUTH WALES; OUTPATIENT CLINICS, HOSPITAL; PATIENT SATISFACTION; PREGNANCY; PRENATAL CARE; QUESTIONNAIRES; SOCIAL CLASS;

EID: 0036897766     PISSN: 13696513     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1369-6513.2002.00201.x     Document Type: Article

References (21)

1. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1997.
2. Ryan M. Using Consumer Preferences in Health Care Decision Making. Office of Health Economics, 1996.
3. Ryan M. Using willingness to pay to assess the benefits of assisted reproductive techniques. Health Economics, 1996; 5: 543-558.
4. Gafni A. Willingness to pay - What's in a name'? Pharmacoeconomics, 1998; 14: 465-470.
5. Johannesson M, Jonsson B. Economic evaluation in health care: Is there a role for cost benefit analysis? Health Policy, 1991; 17: 1-23.
6. Diener A, O'Brien B, Gafni A. Health care contingent valuation studies: A review and classification of the literature. Health Economics 1998; 7: 313-326.
7. Taylor S, Armour C. Measurement of consumer preference for treatments to induce labour: A willingness to pay approach. Health Expectations, 2000; 3: 203-216.
8. Ryan M. Evaluating Assisted Reproductive Technology Programmes: An Australian Pilot Study Using Willingness to Pay. Centre for Health Economics Research and Evaluation Discussion Paper 1994; 26.
9. Bryan S, Buxton M, Sheldon R, Grant A. Magnetic resonance imaging for the investigation of knee injuries: An investigation of preferences. Health Economics 1998; 7: 595-603.
10. Taylor S, Armour C. Measuring benefits of prostaglandin E2 vaginal gel using stated preference discrete choice modelling. Pharmacoeconomics, 2002 (in press).
11. Keirse MJNC, van Oppen ACC. Comparison of prostaglandins and oxytocin for inducing labour. In: Chalmers I, Enkin M, Keirse M (eds). Effective Care in Pregnancy and Childbirth. New York: Oxford Medical, 1989. 1080-1111.
12. Keirse MJNC, van Oppen ACC. Preparing the cervix for induction of labour. In: Chalmers I, Enkin M, Keirse M (eds). Effective Care in Pregnancy and Childbirth. New York: Oxford Medical, 1989. 988-1056
13. Taylor SJ, Peat JK, Armour CL. An evaluation of Prostaglandin E2 vaginal gel use in practice. Journal of Clinical Pharmacy and Therapeutics, 1999; 24: 303-310.
14. Upjohn. Prostin E2 Vaginal Gel. As Close to "Natural" as Labour Induction can be. Upjohn, Sydney, Australia, 1991.
15. Arrow K, Solow R, Portney PR et al. National Oceanic Atmospheric Administration. Report of the NOAA Panel on Contingent Valuation, Vol. 58: Federal Register, 1993. 4607-4614.
16. Donaldson C, Shackley P, Abdalla M. Using willingness to pay to value close substitutes: Carrier screening for cystic fibrosis revisited. Health Economics 1997; 6: 145-159.
17. Hahn GJ, Shapiro SS. A Catalogue and Computer Programme for the Design and Analysis of Orthogonal Symmetric and Asymmetric Fractional Factorial Experiments. Schenectady, NY: General Electric Research and Development Center, 1964.
18. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: An application to in vitro fertilisation. Social Science and Medicine, 1999; 48: 535-546.
19. Ryan M. A role for conjoint analysis in technology assessment in Health care? International Journal of Technology Assessment in Health Care, 1999; 15: 443-457.
20. Davey P, Grainger D, MacMillan J, Rajan N, Aristedes M, Dobson M. Economic evaluation of insulin lispro versus neutral (regular) insulin therapy using a willingness-to-pay approach. Pharmacoeconomics, 1998; 13: 347-358.
21. Culyer AJ, Evans RG. Mark Pauly on welfare economics: Normative rabbits from positive hats. Journal of Health Economics, 1996; 15: 243-251.